Kristina F. Standeven
Leeds, ENG LS29JT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
Journal: Thrombosis and haemostasis
Published: July 21, 2016
Normal Bone Deposition Occurs in Mice Deficient in Factor XIII-A and Transglutaminase 2.
Journal: Matrix biology : journal of the International Society for Matrix Biology
Published: December 18, 2014
Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity.
Journal: Blood
Published: May 24, 2013
Substrates of Factor XIII-A: roles in thrombosis and wound healing.
Journal: Clinical science (London, England : 1979)
Published: October 19, 2012
Thyroid dysfunction and fibrin network structure: a mechanism for increased thrombotic risk in hyperthyroid individuals.
Journal: The Journal of clinical endocrinology and metabolism
Published: March 02, 2012
Elevated properdin and enhanced complement activation in first-degree relatives of South Asian subjects with type 2 diabetes.
Journal: Diabetes care
Published: February 17, 2012
Complement C3 is a novel plasma clot component with anti-fibrinolytic properties.
Journal: Diabetes & vascular disease research
Published: January 19, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026